RT Journal Article
SR Electronic
T1 Circulating-tumor DNA from Two Types of Blood Collection Tubes for Monitoring Tumor Burden Validated with Esophageal Squamous Cell Carcinoma Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.12.20173070
DO 10.1101/2020.08.12.20173070
A1 Fumitaka Endo
A1 Takeshi Iwaya
A1 Yasushi Sasaki
A1 Takehiro Chiba
A1 Mizunori Yaegashi
A1 Kohei Kume
A1 Kei Sato
A1 Atsuhiro Arisue
A1 Ryoko Kawagishi
A1 Teppei Matuo
A1 Yuji Akiyama
A1 Akira Sasaki
A1 Yuji Suzuki
A1 Takashi Tokino
A1 Mari Masuda
A1 Tesshi Yamada
A1 Hidewaki Nakagawa
A1 Satoshi S. Nishizuka
YR 2020
UL http://medrxiv.org/content/early/2020/08/14/2020.08.12.20173070.abstract
AB Objective To evaluate long-term whole blood (WB) storage at room temperature (RT), plasma and peripheral blood mononuclear cell (PBMC) DNA was collected simultaneously using BD Vacutainer® CPTTM Mononuclear Cell Preparation Tubes (CPT) and Streck Cell-Free DNA Blood Collection Tubes (BCT®).Methods Plasma DNA was isolated from both types of tubes at various time points at RT. DNA from PBMCs was extracted using CPT from WB stored in BCT. The extracted DNA was used to monitor esophageal cancer treatment.Results BCT maintained steady levels of plasma DNA for up to nine days. After transfer of BCT-stored WB to CPT, PBMC-DNA were yielded with suitable quality for up to seven days. ctDNA from esophageal cancer patients carrying TP53 mutations reflected treatment efficacy.Conclusion BCT/CPT combinatory procedure allows storage of blood samples for up to seven days at RT for valid clinical assays using ctDNA.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialUMIN000038724Funding StatementThis work was supported by Keiryokai Collaborative Research Grant [#131, #136] and a Grant-in-Aid for Scientific Research KAKENHI [JP16H01578, JP16K19951, JP16K19952, JP17K10605, 19K09224, and JP16H06279].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of Iwate Medical University School of Medicine, Iwate, JapanAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSequence data were deposited in the DNA Data Bank Japan (Accession number JGAS00000000219).